DalsnaFinance › Analyst accuracy › RBC Capital Markets › TMO target
Is Thermo Fisher Scientific Inc. (TMO) a Buy as RBC Restarts Coverage With Sector Perform Rating?
RBC Capital restarted coverage of TMO with a Sector Perform rating and assigned a $490 price objective.
A fact about what RBC Capital Markets published, as reported by Yahoo Finance, not a recommendation from Dalsna Finance; RBC Capital Markets is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.